What recent advances have there been in the use of systemic therapies for the treatment of non-small-cell lung cancer brain metastases? Discover more about the potential efficacy of conventional chemotherapy agents, targeted therapies and immunotherapies in this context.
Browsing: secondary tumor
According to research presented at the National Cancer Research Institute Cancer Conference (held held 2–5 November, Liverpool, UK), scientists have identified a pattern of genetic switches that are linked to breast cancer’s spread to the brain.
Ruth Williamson interviews David J Brenner about advances in the use of radiotherapy to reduce second breast cancers.
Smoking causes adverse outcomes in cancer patients: addressing the evidence base through efficient design
This commentary discusses how smoking can cause adverse effects in cancer patients and highlights the need for clinicians/researchers to account for this when assessing patients.